Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes

Current Genomics

Volumn 11, Issue 8, 2010, Pages 578-583

  Askari, Bahram S ^a   Krajinovic, Maja ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Dihydrofolate reductase (DHFR); Disease susceptibility; Gene; Methotrexate (MTX); Polymorphisms; Therapeutic response

Indexed keywords

DIHYDROFOLATE REDUCTASE; FOLIC ACID; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHORIOCARCINOMA; COLORECTAL CARCINOMA; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DRUG EFFICACY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; NEURAL TUBE DEFECT; NONHODGKIN LYMPHOMA; NONHUMAN; OSTEOSARCOMA; PREMATURE LABOR; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SPINA BIFIDA; TREATMENT OUTCOME;

EID: 78649992238     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920210793360925     Document Type: Article

References (55)

1. Chen, M.J.; Shimada, T.; Moulton, A.D.; Cline, A.; Humphries, R.K.; Maizel, J.; Nienhuis, A.W. The functional human dihydrofolate reductase gene. J. Biol. Chem., 1984, 259(6), 3933-3943.
2. Jensen, D.E.; Black, A.R.; Swick, A.G.; Azizkhan, J.C. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J. Cell. Biochem., 1997, 67(1), 24-31.
3. Blume, S.W.; Meng, Z.; Shrestha, K.; Snyder, R.C.; Emanuel, P.D. The 5'-untranslated RNA of the human dhfr minor transcript alters transcription pre-initiation complex assembly at the major (core) promoter. J. Cell. Biochem., 2003, 88(1), 165-180.
4. Martianov, I.; Ramadass, A.; Serra Barros, A.; Chow, N.; Akoulitchev, A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature, 2007, 445(7128), 666-670.
5. Sohn, K.J.; Jang, H.; Campan, M.; Weisenberger, D.J.; Dickhout, J.; Wang, Y.C.; Cho, R.C.; Yates, Z.; Lucock, M.; Chiang, E.P.; Austin, R.C.; Choi, S.W.; Laird, P.W.; Kim, Y.I. The methylenetetrahydrofolate reductase C677T mutation induces cellspecific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification. Int. J. Cancer, 2009, 124(9), 1999-2005.
6. Assaraf, Y.G. Molecular basis of antifolate resistance. Cancer Metastasis Rev., 2007, 26(1), 153-181.
7. Blaney, J.; Hansch, C.; Silipo, C.; Vittoria, A. Structure-Activity Relationships of Dihydrofolate Reductase Inhibitors. Chem. Rev., 1984, 84(4), 333-407.
8. Morales, C.; Garcia, M.J.; Ribas, M.; Miro, R.; Munoz, M.; Caldas, C.; Peinado, M.A. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells. Mol. Cancer Ther., 2009, 8(2), 424-432.
9. Gorlick, R.; Goker, E.; Trippett, T.; Waltham, M.; Banerjee, D.; Bertino, J.R. Intrinsic and acquired resistance to methotrexate in acute leukemia. N. Engl. J. Med., 1996, 335(14), 1041-1048.
10. Anagnou, N.P.; O'Brien, S.J.; Shimada, T.; Nash, W.G.; Chen, M.J.; Nienhuis, A.W. Chromosomal organization of the human dihydrofolate reductase genes: dispersion, selective amplification, and a novel form of polymorphism. Proc. Natl. Acad. Sci. USA, 1984, 81(16), 5170-5174.
11. Morandi, C.; Masters, J.N.; Mottes, M.; Attardi, G. Multiple forms of human dihydrofolate reductase messenger RNA. Cloning and expression in Escherichia coli of their DNA coding sequence. J. Mol. Biol., 1982, 156(3), 583-607.
12. Busby, A.; Abramsky, L.; Dolk, H.; Armstrong, B.; Addor, M.C.; Anneren, G.; Armstrong, N.; Baguette, A.; Barisic, I.; Berghold, A.; Bianca, S.; Braz, P.; Calzolari, E.; Christiansen, M.; Cocchi, G.; Daltveit, A.K.; De Walle, H.; Edwards, G.; Gatt, M.; Gener, B.; Gillerot, Y.; Gjergja, R.; Goujard, J.; Haeusler, M.; Latos-Bielenska, A.; McDonnell, R.; Neville, A.; Olars, B.; Portillo, I.; Ritvanen, A.; Robert-Gnansia, E.; Rösch, C.; Scarano, G.; Steinbicker, V. Preventing neural tube defects in Europe: a missed opportunity. Reprod. Toxicol., 2005, 20(3), 393-402.
13. Parle-McDermott, A.; Pangilinan, F.; Mills, J.L.; Kirke, P.N.; Gibney, E.R.; Troendle, J.; O'Leary, V.B.; Molloy, A.M.; Conley, M.; Scott, J.M.; Brody, L.C. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am. J. Med. Genet. A., 2007, 143A(11), 1174-1180.
14. Stanislawska-Sachadyn, A.; Brown, K. S.; Mitchell, L. E.; Woodside, J. V.; Young, I. S.; Scott, J. M.; Murray, L.; Boreham, C. A.; McNulty, H.; Strain, J. J.; Whitehead, A. S. An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women. Hum. Genet., 2008, 123(3), 289-95.
15. Botto, L.D.; Yang, Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol., 2000, 151(9), 862-877.
16. Botto, L.D.; Moore, C.A.; Khoury, M.J.; Erickson, J.D. Neuraltube defects. N. Engl. J. Med., 1999, 341(20), 1509-1519.
17. Johnson, W.G.; Stenroos, E.S.; Spychala, J.R.; Chatkupt, S.; Ming, S.X.; Buyske, S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am. J. Med. Genet., 2004, 124A(4), 339-345.
18. Johnson, W.G.; Scholl, T.O.; Spychala, J.R.; Buyske, S.; Stenroos, E.S.; Chen, X. Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor for preterm delivery. Am. J. Clin. Nutr., 2005, 81(3), 664-668.
19. van der Linden, I.J.; Nguyen, U.; Heil, S.G.; Franke, B.; Vloet, S.; Gellekink, H.; den Heijer, M.; Blom, H.J. Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol. Genet. Metab., 2007, 91(1), 98-103.
20. Gellekink, H.; Blom, H.J.; van der Linden, I.J.; den Heijer, M. Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels. Eur. J. Hum. Genet., 2007, 15(1), 103-109.
21. Xu, X.; Gammon, M.D.; Wetmur, J.G.; Rao, M.; Gaudet, M.M.; Teitelbaum, S.L.; Britton, J.A.; Neugut, A.I.; Santella, R.M.; Chen, J. A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am. J. Clin. Nutr., 2007, 85(4), 1098-1102.
22. Kalmbach, R.D.; Choumenkovitch, S.F.; Troen, A.P.; Jacques, P.F.; D'Agostino, R.; Selhub, J. A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate. J. Nutr., 2008, 138(12), 2323-2327.
23. Dulucq, S.; St-Onge, G.; Gagne, V.; Ansari, M.; Sinnett, D.; Labuda, D.; Moghrabi, A.; Krajinovic, M. DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL. Blood, 2008, 111(7), 3692-3700.
24. Al-Shakfa, F.; Dulucq, S.; Brukner, I.; Milacic, I.; Ansari, M.; Beaulieu, P.; Moghrabi, A.; Laverdiere, C.; Sallan, S.E.; Silverman, L.B.; Neuberg, D.; Kutok, J.L.; Sinnett, D.; Krajinovic, M. DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemia. Clin. Cancer. Res., 2009, 15(22), 6931-6938.
25. Kim, Y.I. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J. Nutr., 2005, 135(11), 2703-2709.
26. Gemmati, D.; De Mattei, M.; Catozzi, L.; Della Porta, M.; Serino, M.L.; Ambrosio, C.; Cuneo, A.; Friso, S.; Krampera, M.; Orioli, E.; Zeri, G.; Ongaro, A. DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing? Am. J. Hematol., 2009, 84(8), 526-529.
27. Schwahn, B.; Rozen, R. Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am. J. Pharmacogenomics, 2001, 1(3), 189-201.
28. Krajinovic, M.; Lamothe, S.; Labuda, D.; Lemieux-Blanchard, E.; Theoret, Y.; Moghrabi, A.; Sinnett, D. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acutelymphoblastic leukemia. Blood, 2004, 103(1), 252-257.
29. Cam, R.; Eroglu, A.; Egin, Y.; Akar, N. Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer. Breast Cancer Res. Treat., 2009, 115(2), 431-432.
30. Stolzenberg-Solomon, R.Z.; Chang, S.C.; Leitzmann, M.F.; Johnson, K.A.; Johnson, C.; Buys, S.S.; Hoover, R.N.; Ziegler, R.G. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am. J. Clin. Nutr., 2006, 83(4), 895-904.
31. Hazra, A.; Fuchs, C.S.; Kawasaki, T.; Kirkner, G.J.; Hunter, D.J.; Ogino, S. Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Cancer Causes Control, 2010, 21(3), 331-345.
32. Curtin, K.; Slattery, M.L.; Ulrich, C.M.; Bigler, J.; Levin, T.R.; Wolff, R.K.; Albertsen, H.; Potter, J.D.; Samowitz, W.S. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis, 2007, 28(8), 1672-1679.
33. Levine, A.J.; Figueiredo, J.C.; Lee, W.; Conti, D.V.; Kennedy, K.; Duggan, D.J.; Poynter, J.N.; Campbell, P.T.; Newcomb, P.; Martinez, M.E.; Hopper, J.L.; Le Marchand, L.; Baron, J.A.; Limburg, P.J.; Ulrich, C.M.; Haile, R.W. A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 2010, 19(7), 1812-1821.
34. Ansari, M.; Krajinovic, M. Pharmacogenomics of acute leukemia. Pharmacogenomics, 2007, 8(7), 817-834.
35. Banerjee, D.; Mayer-Kuckuk, P.; Capiaux, G.; Budak-Alpdogan, T.; Gorlick, R.; Bertino, J.R. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim. Biophys. Acta, 2002, 1587(2-3), 164-173.
36. Matherly, L.H.; Taub, J.W.; Ravindranath, Y.; Proefke, S.A.; Wong, S.C.; Gimotty, P.; Buck, S.; Wright, J.E.; Rosowsky, A. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia. Blood, 1995, 85, 500-509.
37. Serra, M.; Reverter-Branchat, G.; Maurici, D.; Benini, S.; Shen, J.N.; Chano, T.; Hattinger, C.M.; Manara, M.C.; Pasello, M.; Scotlandi, K.; Picci, P. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells. Ann. Oncol., 2004, 15(1), 151-160.
38. Goker, E.; Waltham, M.; Kheradpour, A.; Trippett, T.; Mazumdar, M.; Elisseyeff, Y.; Schnieders, B.; Steinherz, P.; Tan, C.; Berman, E., et al. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood, 1995, 86(2), 677-684.
39. Goto, Y.; Yue, L.; Yokoi, A.; Nishimura, R.; Uehara, T.; Koizumi, S.; Saikawa, Y. A novel single-nucleotide polymorphism in the 3'- untranslated region of the human dihydrofolate reductase gene with enhanced expression. Clin. Cancer Res., 2001, 7(7), 1952-1956.
40. Mishra, P.J.; Humeniuk, R.; Mishra, P.J.; Longo-Sorbello, G.S.; Banerjee, D.; Bertino, J.R. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc. Natl. Acad. Sci. USA, 2007, 104(33), 13513-13518.
41. Ambros, V. The functions of animal microRNAs. Nature, 2004, 431(7006), 350-355.
42. Garzon, R.; Calin, G.A.; Croce, C.M. MicroRNAs in Cancer. Annu. Rev. Med., 2009, 60, 167-179.
43. He, L.; Thomson, J.M.; Hemann, M.T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S.W.; Hannon, G.J.; Hammond, S.M. A microRNA polycistron as a potential human oncogene. Nature, 2005, 435(7043), 828-833.
44. Song, B.; Wang, Y.; Titmus, M.A.; Botchkina, G.; Formentini, A.; Kornmann, M.; Ju, J. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol. Cancer, 2010, 9, 96.
45. Mishra, P.J.; Banerjee, D.; Bertino, J.R. MiRSNPs or MiRpolymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics. Cell Cycle, 2008, 7(7), 853-858.
46. Mishra, P.J.; Bertino, J.R. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics, 2009, 10(3), 399-416.
47. Fujii, H.; Shimada, T. Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene. J. Biol. Chem., 1989, 264(17), 10057-10064.
48. Nakajima, E.; Orimo, H.; Ikejima, M.; Shimada, T. Nine-bp repeat polymorphism in exon 1 of the hMSH3 gene. Jpn. J. Hum. Genet., 1995, 40(4), 343-345.
49. Turesson, C.; Matteson, E.L. Genetics of rheumatoid arthritis. Mayo Clin. Proc., 2006, 81(1), 94-101.
50. Wessels, J.A.; de Vries-Bouwstra, J.K.; Heijmans, B.T.; Slagboom, P.E.; Goekoop-Ruiterman, Y.P.; Allaart, C.F.; Kerstens, P.J.; van Zeben, D.; Breedveld, F.C.; Dijkmans, B.A.; Huizinga, T.W.; Guchelaar, H.J. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum., 2006, 54(4), 1087-1095.
51. Ranganathan, P. An update on methotrexate pharmacogenetics in rheumatoid arthritis. Pharmacogenomics, 2008, 9(4), 439-451.
52. Chandran, V.; Siannis, F.; Rahman, P.; Pellett, F.J.; Farewell, V.T.; Gladman, D.D. Folate Pathway Enzyme Gene Polymorphisms and the Efficacy and Toxicity of Methotrexate in Psoriatic Arthritis. J. Rheumatol., 2010, 37(7), 1508-1512.
53. Sharma, S.; Das, M.; Kumar, A.; Marwaha, V.; Shankar, S.; Singh, P.; Raghu, P.; Aneja, R.; Grover, R.; Arya, V.; Dhir, V.; Gupta, R.; Kumar, U.; Juyal, R.C.; K, T.B. Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians. Pharmacogenet. Genomics, 2009, 19(10), 823-828.
54. Ranganathan, P. Association of methotrexate effects and singlenucleotide polymorphisms in the folate pathway in rheumatoid arthritis: comment on the article by Wessels et al. Arthritis Rheum., 2006, 54(10), 3372; author reply 3372-3373.
55. The National Center for Biotechnology Information. SNP: single nucleotide polymorphism. Available at: http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp&cmd=search&term=dbSNP (Accessed July 15, 2010).